Skip to content

Wuqinxi for Patients with Gastrointestinal Cancer undergoing Chemotherapy and at High Risk for Depression: A Randomized Clinical Trial

Monkey Frolic for Patients with Gastrointestinal Cancer undergoing Chemotherapy and at High Risk for Depression: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043417
Enrollment
Unknown
Registered
2021-02-16
Start date
2019-01-24
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Cancer

Interventions

Experimental group:monkey frolic exercise
control group:conventional treatment

Sponsors

Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) diagnosed with stage I to IV gastrointestinal cancer by pathological examination and were undergoing chemotherapy; (2) between the ages of 18 and 70 years; (3) at high risk for depression, determined by a standard score of >= 50 and =60 on the Karnofsky performance status scale; (5) survival time predicted to be >6 months by two chief oncologists; (6) was aware of his/her condition; (7) could understand, read, and write in Chinese; (8) volunteered to participate in this trial and signed an informed consent document.

Exclusion criteria

Exclusion criteria: (1) Past or present history of mental disorders and cognitive impairment; (2) other serious physical diseases except gastrointestinal tumors; (3) any contraindication of Health Qigong therapy (weak constitution, non-functioning limbs, body dysfunction); (4) been simultaneously treated with radiotherapy or other invasive therapy; (5) recently encountered major setbacks; (6) undergone psychotherapy or taken any psychiatric medication; (7) participated in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Self-rating Depression Scale (SDS);Automatic Thoughts Questionnaire (ATQ);

Secondary

MeasureTime frame
the European Organization for Research and Treatment of Cancer (EORTC) Core Quality of Life Questionnaire-core30 (QLQ-C30);

Countries

China

Contacts

Public ContactQing-Mei Hou

Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine

13951669569@126.com+86 18051981018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026